Currency:JPYAug 9, 2024
Revenue
EPS
EBIT
No Data
BrightPath Biotherapeutics: 1Q financial results briefing for March 2025 [Japan standard] (non-consolidated).
Aug 9 02:00 ET
BrightPath Biotherapeutics: Confirmation letter
Jun 21 02:33 ET
BrightPath Biotherapeutics: Securities Report - 21st term (April 1, 2023 - March 31, 2024)
Jun 21 02:32 ET
BRIGHTPATH BIOTHERAPEUTICS: (Correction) Partial Corrections to the “Financial Results Summary for the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Unconsolidated)”
May 10 04:30 ET
Read more